IMV Inc. (IMV) Reports Q2 Loss of $0.11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. AMZN
2. INTC
3. COIN
4. PINS
5. RDDT
6. FSLR
7. SNDK
8. FND
9. RIVN
10. SBUX

Go back to IMV Inc. (IMV) Reports Q2 Loss of $0.11

IMV Inc. Announces Second Quarter 2021 Financial and Operational Results

August 11, 2021 7:05 AM EDT

Appointed Andrew Hall, Chief Business Officer, as interim CEO, Jeremy Graff, PhD as Chief Scientific Officer, Stanley Frankel, MD and Jose Iglesias, MD as Clinical Advisors Strengthened financial position and extended cash runway with the completion of a $25M financing resulting in pro-forma cash and cash equivalents of $45.8 million on June 30th, 2021 Completed the DeCidE1 Phase 2 clinical study in advanced, recurrent ovarian cancer. Translational analyses confirm generation of tumor-antigen directed T cells by maveropepimut-S Initiated Phase 2B trial in... More